NOKOMIS, Fla.--(BUSINESS WIRE)--Joining forces with Nano3D Biosciences is the first step in Rainbow Coral Corp.’s (OTCBB:RBCC) plans to take biotechnology out of the laboratory and into the marketplace.
“It’s our goal to help create a new business model to widely distribute the Bio-Assembler system into the health and research marketplace,” said RBCC CEO Patrick Brown. “This is a revolutionary cell culturing system that will dramatically shorten the development pipeline for cellular research into cures for chronic illnesses and debilitating injuries.”